News
The latest health updates include Centene's improved profitability forecast, US-initiated healthcare data-sharing plans ...
SHOPPING: Designed to treat congestion, runny nose, and itchiness, the SONU Band is a groundbreaking treatment that uses ...
Over the past decade, health insurance companies have increasingly embraced the use of artificial intelligence algorithms – ...
Avidity Biosciences saw its share prices increase by 9.21 percent on Friday to end at $36.27 apiece as investor sentiment was bolstered by the Food and Drug Administration’s (FDA) breakthrough ...
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) is leading innovation in treating metabolic dysfunction-associated ...
From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.
2d
Que.com on MSNAI in FDA Drug Approvals Sparks Controversy Over Fabricated StudiesIn recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...
Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...
U.S. Food and Drug Administration employees told CNN that Elsa — the AI model that’s supposed to help speed up approvals of pharmaceuticals and medical devices — isn’t working great. Instead, it cites ...
FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.
But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...
Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is getting better, and use is not mandatory.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results